MedPath

A prospective study investivating the relationship between vitamin B6 status and cytopenias in patients with hematological disorders.

Not Applicable
Conditions
hematological disorders
Registration Number
JPRN-UMIN000017834
Lead Sponsor
Juntendo University Hospital
Brief Summary

23 patients (12 primary myelofibrosis patients and 11 secondary myelofibrosis patients) were analyzed. A total of 16 out of 23 patients (69.6%) were found to have VB6 deficiency, but VB6 supplementation with pyridoxal phosphate hydrate did not improve hemoglobin levels in any of the patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
23
Inclusion Criteria

Not provided

Exclusion Criteria

1. patients with Parkinson's disease or Parikinson's syndrome 2. patients under treatment with levodopa

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
hemoglobin and transfusion frequencies after administration of vitamin B6
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath